Literature DB >> 10608918

Acetyl-L-carnitine.

.   

Abstract

Acetyl-L-carnitine (ALC) is an ester of the trimethylated amino acid, L-carnitine, and is synthesized in the human brain, liver, and kidney by the enzyme ALC-transferase. Acetyl-L-carnitine facilitates the uptake of acetyl CoA into the mitochondria during fatty acid oxidation, enhances acetylcholine production, and stimulates protein and membrane phospholipid synthesis. ALC, similar in structure to acetylcholine, also exerts a cholinomimetic effect. Studies have shown that ALC may be of benefit in treating Alzheimer's dementia, depression in the elderly, HIV infection, diabetic neuropathies, ischemia and reperfusion of the brain, and cognitive impairment of alcoholism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10608918

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  5 in total

1.  Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury.

Authors:  Samir P Patel; Patrick G Sullivan; Travis S Lyttle; Alexander G Rabchevsky
Journal:  J Neurochem       Date:  2010-04-23       Impact factor: 5.372

Review 2.  Targeting mitochondrial function for the treatment of acute spinal cord injury.

Authors:  Melanie L McEwen; Patrick G Sullivan; Alexander G Rabchevsky; Joe E Springer
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 3.  Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity.

Authors:  V Calabrese; G Scapagnini; A M Giuffrida Stella; T E Bates; J B Clark
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 4.  The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review.

Authors:  Jillian Poles; Elisa Karhu; Megan McGill; H Reginald McDaniel; John E Lewis
Journal:  J Clin Transl Res       Date:  2021-05-27

5.  Self-help interventions for depressive disorders and depressive symptoms: a systematic review.

Authors:  Amy J Morgan; Anthony F Jorm
Journal:  Ann Gen Psychiatry       Date:  2008-08-19       Impact factor: 3.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.